Over 125 Global Pharmaceutical Companies Adopt Veeva Vault CRM Accelerating Autonomous AI in Industry

Veeva Systems Accelerates AI Transformation in Life Sciences

Veeva Systems, a global pioneer in SaaS solutions for the life sciences sector, has recently revealed that over 125 pharmaceutical companies, including top 20 biopharma players, are now actively using their next-generation customer relationship management (CRM) system, Veeva Vault CRM. This milestone marks a significant step toward accelerating the industry's transition to an agentic AI framework.

As of March 3, 2026, the implementation of Vault CRM is taking shape across key regions—encompassing the United States, Europe, and Japan. This transformative initiative highlights the powerful business value derived from its advanced features tailored to industry and regional needs, encompassing compliance, workflow management, and agent capabilities. Vault CRM supports the entire product lifecycle, from preparing for market entry with new drugs to optimizing the performance of established brands, thus facilitating complex customer engagements by providing the necessary foundation for commercial and medical teams.

Arno Sosna, President of Veeva's CRM Suite, emphasized the growing adoption of Vault CRM, expressing that